14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ARAI vs MLAB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARAI carries a Unified Composite Score of 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin), whereas MLAB carries 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin).
Growth vs. Quality Trade-Off: MLAB earns the overall head-to-head edge with a stronger Unified Composite Score (55.4/100 HOLD vs. ARAI 34.4/100 SELL) and 1.13β · 55% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARAI vs MLAB. Trailing 12-month operating profitability (ARAI -18105.8% vs MLAB 10.4%) and valuation multiples (ARAI N/M vs MLAB 23.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Scientific & Technical Instruments value chain with $749.8M market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment54.4% of Rev ($137M)
90D Engineering Disclosures0 Published
Investor FAQ ARAI vs MLAB Key Questions & Quantitative Answers
As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARAI carries a Unified Composite Score of 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin), whereas MLAB carries 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin). Growth vs. Quality Trade-Off: MLAB earns the overall head-to-head edge with a stronger Unified Composite Score (55.4/100 HOLD vs. ARAI 34.4/100 SELL) and 1.13β · 55% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
MLAB leads the Growth & Scale pillar: ARAI posts +432.9% YoY revenue growth and +0.0% YoY earnings growth on $84,400 TTM revenue (100.0% gross margin, -18105.8% operating margin), compared with MLAB at +2.6% YoY revenue growth and +67.0% YoY earnings growth on $251M TTM revenue (64.8% gross margin, 10.4% operating margin). On trailing 12-month operating scale, ARAI generates $84,400 in USD-normalized revenue versus $251M for MLAB. In operating R&D and SG&A reinvestment, ARAI deploys N/A (0 90-day corporate R&D disclosures) versus 54.4% of Rev ($137M) (0 disclosures) for MLAB.
MLAB screens cheaper on headline valuation multiples. ARAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 55.5x EV/Revenue (unreported EBITDA margin), whereas MLAB trades at 23.7x Forward P/E, 115.0x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (19.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARAI (-840.7% ROE) versus MLAB (3.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ARAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (-4.44β · 11485% Vol realized risk). By comparison, MLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.13β · 55% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.